Wall Street brokerages expect Cabot Corporation (NYSE:CBT) to post earnings per share of $0.79 for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Cabot’s earnings, with estimates ranging from $0.73 to $0.95. Cabot posted earnings per share of $0.84 in the same quarter last year, which indicates a negative year over year growth rate of 6%. The business is expected to issue its next quarterly earnings report on Wednesday, February 7th.

According to Zacks, analysts expect that Cabot will report full year earnings of $3.78 per share for the current financial year, with EPS estimates ranging from $3.70 to $3.90. For the next financial year, analysts forecast that the business will report earnings of $4.17 per share, with EPS estimates ranging from $4.05 to $4.40. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Cabot.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.91 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.93 by ($0.02). Cabot had a return on equity of 15.11% and a net margin of 8.87%. The company had revenue of $723.00 million for the quarter, compared to analyst estimates of $683.30 million. During the same quarter in the previous year, the firm posted $1.00 earnings per share. The company’s quarterly revenue was up 16.8% on a year-over-year basis.

A number of research firms recently issued reports on CBT. Zacks Investment Research downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research report on Tuesday, November 7th. Jefferies Group restated a “buy” rating and set a $74.00 target price on shares of Cabot in a research report on Friday, November 3rd. KeyCorp restated a “hold” rating on shares of Cabot in a research report on Wednesday, November 1st. Loop Capital began coverage on shares of Cabot in a research report on Thursday, September 28th. They set a “hold” rating and a $59.00 target price for the company. Finally, J P Morgan Chase & Co upgraded shares of Cabot from a “neutral” rating to an “overweight” rating and set a $57.00 target price for the company in a research report on Tuesday, August 15th. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $61.14.

In other Cabot news, insider Hobart Kalkstein sold 3,881 shares of Cabot stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $53.39, for a total value of $207,206.59. Following the completion of the transaction, the insider now owns 27,736 shares of the company’s stock, valued at $1,480,825.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.50% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. AXA increased its holdings in Cabot by 21.5% in the third quarter. AXA now owns 172,170 shares of the specialty chemicals company’s stock valued at $9,607,000 after buying an additional 30,450 shares in the last quarter. Public Employees Retirement System of Ohio increased its holdings in Cabot by 51.9% in the third quarter. Public Employees Retirement System of Ohio now owns 93,931 shares of the specialty chemicals company’s stock valued at $5,241,000 after buying an additional 32,110 shares in the last quarter. FrontFour Capital Group LLC purchased a new position in Cabot in the third quarter valued at $824,000. California Public Employees Retirement System increased its holdings in Cabot by 4.4% in the third quarter. California Public Employees Retirement System now owns 129,381 shares of the specialty chemicals company’s stock valued at $7,219,000 after buying an additional 5,481 shares in the last quarter. Finally, Point72 Asset Management L.P. purchased a new position in Cabot in the third quarter valued at $3,739,000. 84.88% of the stock is owned by institutional investors.

Shares of Cabot (NYSE:CBT) opened at $60.51 on Friday. Cabot has a one year low of $50.21 and a one year high of $64.66. The company has a current ratio of 1.70, a quick ratio of 1.17 and a debt-to-equity ratio of 0.41. The company has a market cap of $3,700.00, a price-to-earnings ratio of 17.85, a PEG ratio of 1.62 and a beta of 1.11.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Shareholders of record on Friday, November 24th will be issued a $0.315 dividend. The ex-dividend date of this dividend is Wednesday, November 22nd. This represents a $1.26 dividend on an annualized basis and a yield of 2.08%. Cabot’s payout ratio is 33.07%.

TRADEMARK VIOLATION WARNING: This piece was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/12/02/zacks-analysts-expect-cabot-corporation-cbt-will-post-earnings-of-0-79-per-share.html.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Get a free copy of the Zacks research report on Cabot (CBT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with MarketBeat.com's FREE daily email newsletter.